{"id":670301,"date":"2023-09-29T20:44:01","date_gmt":"2023-09-29T20:44:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=670301"},"modified":"2023-09-29T20:44:01","modified_gmt":"2023-09-29T20:44:01","slug":"chronic-venous-insufficiency-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-verigraft-serenagroup","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/chronic-venous-insufficiency-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-verigraft-serenagroup_670301.html","title":{"rendered":"Chronic Venous Insufficiency Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies &#8211; Verigraft, SerenaGroup"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1695965081.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Chronic Venous Insufficiency Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Verigraft, SerenaGroup\" src=\"https:\/\/www.abnewswire.com\/uploads\/1695965081.jpeg\" alt=\"Chronic Venous Insufficiency Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Verigraft, SerenaGroup\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Chronic Venous Insufficiency Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Chronic Venous Insufficiency Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Chronic Venous Insufficiency, historical and forecasted epidemiology as well as the Chronic Venous Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>DelveInsight has launched a new report on&nbsp;&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-venous-insufficiency-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Chronic Venous Insufficiency &#8211; Market Insights, Epidemiology, and Market Forecast-2032<\/a>&rdquo;.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the&nbsp;Chronic Venous Insufficiency Market Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>As per the study conducted by Owayed Al Shammeri et al. (2014),&nbsp; Chronic Venous Insufficiency (CVI) commonly affects lower limbs with a prevalence ranging between 25&ndash;40% and 10&ndash;20% in women and men, respectively. The annual incidence is 2&ndash;6% in women and 1.9% in men.<\/li>\n<li>As per the study conducted by Owayed Al Shammeri et al. (2014),. Among all chronic venous insufficiency patients, approximately 1% to 2.7% will develop a venous stasis ulcer. The formation of an ulcer carries a poor prognosis, with 40% of patients developing recurrence despite standard treatment. Management of chronic venous insufficiency accounts for approximately 2% of the United States&rsquo; total healthcare.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Request for a sample report @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/chronic-venous-insufficiency-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/chronic-venous-insufficiency-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Chronic Venous Insufficiency market report covers a descriptive overview and comprehensive insight of the Chronic Venous Insufficiency Epidemiology and Chronic Venous Insufficiency&nbsp; market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Chronic Venous Insufficiency market report provides insights on the current and emerging therapies.<\/li>\n<li>Chronic Venous Insufficiency market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Chronic Venous Insufficiency market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Chronic Venous Insufficiency market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Chronic Venous Insufficiency Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Chronic venous insufficiency (CVI) typically refers to lower extremity oedema, skin trophic changes, and discomfort secondary to venous hypertension. Chronic venous insufficiency pathophysiology is either due to reflux (backward flow) or obstruction of venous blood flow. Chronic venous insufficiency can develop from the protracted valvular incompetence of superficial veins, deep veins, or perforating veins that connect them. In all cases, the result is venous hypertension of the lower extremities.<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-venous-insufficiency-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Chronic Venous Insufficiency Market<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The dynamics of the&nbsp;<strong>Chronic Venous Insufficiency market<\/strong>&nbsp;is anticipated to change in the coming years owing to the expected launch of emerging therapies by companies such as Verigraft, SerenaGroup, and others during the study period 2019-2032.<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-venous-insufficiency-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><strong>Chronic Venous Insufficiency Emerging Therapy Assessment<\/strong><\/a><\/p>\n<ul style=\"text-align: justify;\">\n<li>P-TEV: Verigraft<\/li>\n<li>TR 987: SerenaGroup.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Chronic Venous Insufficiency Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Chronic Venous Insufficiency Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Chronic Venous Insufficiency Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Chronic Venous Insufficiency Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Chronic Venous Insufficiency&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Chronic Venous Insufficiency Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Chronic Venous Insufficiency Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Chronic Venous Insufficiency Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Chronic Venous Insufficiency Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Chronic Venous Insufficiency Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Request for a sample report @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/chronic-venous-insufficiency-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/chronic-venous-insufficiency-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Chronic Venous Insufficiency Pipeline&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&#8220;Chronic Venous Insufficiency Pipeline Insight, 2023&#8221; report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Chronic Venous Insufficiency market. A detailed picture of the Chronic Venous Insufficiency pipeline landscape is provided, which includes the disease overview and Chronic Venous Insufficiency treatment guidelines.<\/p>\n<p style=\"text-align: justify;\"><strong>Chronic Venous Insufficiency Epidemiology<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8216;Chronic Venous Insufficiency Epidemiology Forecast to 2032&#8217; report delivers an in-depth understanding of the disease, historical and forecasted Chronic Venous Insufficiency epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=chronic-venous-insufficiency-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-verigraft-serenagroup\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +91-9650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=chronic-venous-insufficiency-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-verigraft-serenagroup\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chronic Venous Insufficiency Market DelveInsight&#8217;s &#8220;Chronic Venous Insufficiency Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Chronic Venous Insufficiency, historical and forecasted epidemiology as well as the Chronic Venous Insufficiency market trends in the United &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/chronic-venous-insufficiency-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-verigraft-serenagroup_670301.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-670301","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/670301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=670301"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/670301\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=670301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=670301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=670301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}